BACKGROUND: Nonmelanoma skin cancer (NMSC) is a growing public health problem among Caucasians, thus mortality data that may provide insight into the clinical course and foster our understanding of NMSC are important. OBJECTIVES: We examined total and cause-specific mortality among patients with NMSC registered in the Danish Cancer Registry from 1978 to 2001. METHODS: A total of 82 837 patients with basal cell carcinoma (BCC) and 13 453 patients with squamous cell carcinoma (SCC) were followed through the National Death Registry for specific causes of death. Standardized mortality ratios (SMRs) were computed based on mortality rates in the general population. RESULTS: Among patients with BCC, we found a slightly reduced total mortality [SMR 0.97, 95% confidence interval (CI) 0.96-0.98] with decreased SMRs seen for chronic obstructive pulmonary disease (COPD), cardiovascular disease (CVD) and diabetes mellitus. The SMR for suicide was increased. Among patients with SCC, we found an increased total mortality (SMR 1.30, 95% CI 1.26-1.33) due primarily to excess deaths from cancers, COPD, CVD and infectious diseases. CONCLUSIONS: We found markedly different mortality patterns among patients with BCC and those with SCC, suggesting important differences in the clinical course of these patients.
BACKGROUND:Nonmelanoma skin cancer (NMSC) is a growing public health problem among Caucasians, thus mortality data that may provide insight into the clinical course and foster our understanding of NMSC are important. OBJECTIVES: We examined total and cause-specific mortality among patients with NMSC registered in the Danish Cancer Registry from 1978 to 2001. METHODS: A total of 82 837 patients with basal cell carcinoma (BCC) and 13 453 patients with squamous cell carcinoma (SCC) were followed through the National Death Registry for specific causes of death. Standardized mortality ratios (SMRs) were computed based on mortality rates in the general population. RESULTS: Among patients with BCC, we found a slightly reduced total mortality [SMR 0.97, 95% confidence interval (CI) 0.96-0.98] with decreased SMRs seen for chronic obstructive pulmonary disease (COPD), cardiovascular disease (CVD) and diabetes mellitus. The SMR for suicide was increased. Among patients with SCC, we found an increased total mortality (SMR 1.30, 95% CI 1.26-1.33) due primarily to excess deaths from cancers, COPD, CVD and infectious diseases. CONCLUSIONS: We found markedly different mortality patterns among patients with BCC and those with SCC, suggesting important differences in the clinical course of these patients.
Authors: B J Marston; J F Plouffe; T M File; B A Hackman; S J Salstrom; H B Lipman; M S Kolczak; R F Breiman Journal: Arch Intern Med Date: 1997 Aug 11-25
Authors: Mackenzie R Wehner; Wilmarie Cidre Serrano; Adi Nosrati; Patrick Michael Schoen; Mary-Margaret Chren; John Boscardin; Eleni Linos Journal: J Am Acad Dermatol Date: 2017-11-13 Impact factor: 11.527
Authors: Virginia Barton; Kent Armeson; Shalaka Hampras; Laura K Ferris; Kala Visvanathan; Dana Rollison; Anthony J Alberg Journal: Arch Dermatol Res Date: 2017-03-11 Impact factor: 3.017
Authors: Margaret R Karagas; Janet L Peacock; Judy R Rees; M Scot Zens; Maria O Celaya; Bruce L Riddle Journal: Int J Cancer Date: 2015-01-29 Impact factor: 7.396
Authors: Georgina M Hosang; Sheri L Johnson; Janice Kiecolt-Glaser; Michael P Di Gregorio; David R Lambert; Mark A Bechtel; Dean W Hearne; Joel B Herron; Ronald Glaser Journal: Child Abuse Negl Date: 2013-01-21
Authors: Jorge R Toro; Patrick W Blake; Magnus Björkholm; Sigurdur Y Kristinsson; Zhuoqiao Wang; Ola Landgren Journal: Haematologica Date: 2009-10 Impact factor: 9.941
Authors: Sigrun A J Schmidt; Anne G Ording; Erzsébet Horváth-Puhó; Henrik T Sørensen; Victor W Henderson Journal: PLoS One Date: 2017-02-22 Impact factor: 3.240
Authors: James Small; Kristin Wallace; Elizabeth G Hill; Bruce H Thiers; Brian C Leach; Anthony J Alberg Journal: Cancer Causes Control Date: 2020-10-29 Impact factor: 2.506